Erratum to ' Taking action on climate change: Testimonials and position statement from the International League Against Epilepsy Climate Change Commission' [Seizure Volume 106, March 2023, Pages 68-75]

Angel Aledo-Serrano¹, Giulia Battaglia², Stephen Blenkinsop³, Norman Delanty⁴, Hasnaa M Elbendary⁵, Sara Eyal⁶, Alla Guekht⁷, Medine I Gulcebi⁸, David C Henshall⁹, Michael S Hildebrand¹⁰, Bernadette Macrohon¹¹, Priyanka Madaan¹², Janet Mifsud¹³, James D Mills¹⁴, Kathryn Hodgson Neill¹⁵, Alessia Romagnolo¹⁶, Annamaria Vezzani¹⁷, Sanjay M Sisodiya¹⁸

Affiliations

¹ Epilepsy Program, Neurology Department, Hospital Ruber Internacional, Madrid, Spain.
² Neurology Unit, IRCCS Policlinico San Donato, Piazza Malan 2, 20097 San Donato Milanese (MI), Italy.
³ School of Engineering, Newcastle University, Newcastle upon Tyne, UK.
⁴ Department of Neurology, Beaumont Hospital, School of Pharmacy and Biomedical Sciences, and FutureNeuro Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.
⁵ Clinical Genetics Department, Human Genetics and Genome Research Institute National Research Centre, Cairo, Egypt.
⁶ Institute for Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
⁷ Moscow Research and Clinical Center for Neuropsychiatry and Pirogov Russian National Research, Moscow, Russian Federation.
⁸ Department of Medical Pharmacology, Marmara University Faculty of Medicine, Istanbul, Turkey; Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK; Chalfont Centre for Epilepsy, Chalfont St Peter, UK.
⁹ Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland; FutureNeuro, Science Foundation Ireland Research Centre for Chronic and Rare Neurological Diseases, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland.
¹⁰ Epilepsy Research Centre, Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Australia; Neuroscience Group, Murdoch Children's Research Institute, Melbourne, Australia.
¹¹ Department of Pediatrics, Zamboanga City Medical Center, Zamboanga City, Philippines.
¹² Department of Pediatric Neurology, Amrita Institute of Medical Sciences, Faridabad, Haryana, India.
¹³ Department of Clinical Pharmacology and Therapeutics, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
¹⁴ Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK; Chalfont Centre for Epilepsy, Chalfont St Peter, UK; Amsterdam UMC, Department of (Neuro)Pathology, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, Netherlands.
¹⁵ International League Against Epilepsy (ILAE), Dublin, Ireland.
¹⁶ Amsterdam UMC, Department of (Neuro)Pathology, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, Netherlands.
¹⁷ Department of Acute Brain Injury; Lab. of Epilepsy and Therapeutic Strategies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
¹⁸ Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK; Chalfont Centre for Epilepsy, Chalfont St Peter, UK. Electronic address: s.sisodiya@ucl.ac.uk.

PMID: 37639957
DOI: 10.1016/j.seizure.2023.08.013

Free article

Published Erratum

Erratum to ' Taking action on climate change: Testimonials and position statement from the International League Against Epilepsy Climate Change Commission' [Seizure Volume 106, March 2023, Pages 68-75]

Angel Aledo-Serrano et al. Seizure. 2023 Oct.

Free article

. 2023 Oct:111:164.

doi: 10.1016/j.seizure.2023.08.013. Epub 2023 Aug 26.

Authors

Affiliations

¹ Epilepsy Program, Neurology Department, Hospital Ruber Internacional, Madrid, Spain.
² Neurology Unit, IRCCS Policlinico San Donato, Piazza Malan 2, 20097 San Donato Milanese (MI), Italy.
³ School of Engineering, Newcastle University, Newcastle upon Tyne, UK.
⁴ Department of Neurology, Beaumont Hospital, School of Pharmacy and Biomedical Sciences, and FutureNeuro Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.
⁵ Clinical Genetics Department, Human Genetics and Genome Research Institute National Research Centre, Cairo, Egypt.
⁶ Institute for Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
⁷ Moscow Research and Clinical Center for Neuropsychiatry and Pirogov Russian National Research, Moscow, Russian Federation.
⁸ Department of Medical Pharmacology, Marmara University Faculty of Medicine, Istanbul, Turkey; Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK; Chalfont Centre for Epilepsy, Chalfont St Peter, UK.
⁹ Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland; FutureNeuro, Science Foundation Ireland Research Centre for Chronic and Rare Neurological Diseases, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, Ireland.
¹⁰ Epilepsy Research Centre, Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Australia; Neuroscience Group, Murdoch Children's Research Institute, Melbourne, Australia.
¹¹ Department of Pediatrics, Zamboanga City Medical Center, Zamboanga City, Philippines.
¹² Department of Pediatric Neurology, Amrita Institute of Medical Sciences, Faridabad, Haryana, India.
¹³ Department of Clinical Pharmacology and Therapeutics, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
¹⁴ Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK; Chalfont Centre for Epilepsy, Chalfont St Peter, UK; Amsterdam UMC, Department of (Neuro)Pathology, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, Netherlands.
¹⁵ International League Against Epilepsy (ILAE), Dublin, Ireland.
¹⁶ Amsterdam UMC, Department of (Neuro)Pathology, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, Netherlands.
¹⁷ Department of Acute Brain Injury; Lab. of Epilepsy and Therapeutic Strategies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
¹⁸ Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK; Chalfont Centre for Epilepsy, Chalfont St Peter, UK. Electronic address: s.sisodiya@ucl.ac.uk.

PMID: 37639957
DOI: 10.1016/j.seizure.2023.08.013

No abstract available

PubMed Disclaimer

Erratum for

Taking action on climate change: Testimonials and position statement from the International League Against Epilepsy Climate Change Commission.
Aledo-Serrano A, Battaglia G, Blenkinsop S, Delanty N, Elbendary HM, Eyal S, Guekht A, Gulcebi MI, Henshall DC, Hildebrand MS, Macrohon B, Madaan P, Mifsud J, Mills JD, Neill KH, Romagnolo A, Vezzani A, Sisodiya SM. Aledo-Serrano A, et al. Seizure. 2023 Mar;106:68-75. doi: 10.1016/j.seizure.2023.02.003. Epub 2023 Feb 4. Seizure. 2023. PMID: 36774776

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Erratum to ' Taking action on climate change: Testimonials and position statement from the International League Against Epilepsy Climate Change Commission' [Seizure Volume 106, March 2023, Pages 68-75]

Affiliations

Erratum to ' Taking action on climate change: Testimonials and position statement from the International League Against Epilepsy Climate Change Commission' [Seizure Volume 106, March 2023, Pages 68-75]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources